2-methylpentane has been researched along with Idiopathic Inflammatory Myopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannasch, H; Braig, D; Eisenhardt, SU; Goerendt, K; Habersberger, J; Kolodgie, F; Maurer, V; Peter, K; Scheichl, A; Schmidt, Y; Stark, GB; Thiele, JR; Virmani, R; von Dobschütz, E; Woollard, KJ | 1 |
1 other study(ies) available for 2-methylpentane and Idiopathic Inflammatory Myopathies
| Article | Year |
|---|---|
Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
Topics: Animals; Anti-Inflammatory Agents; Biopolymers; C-Reactive Protein; Carrier Proteins; Cell Adhesion; Cell Membrane; Chemotaxis, Leukocyte; Complement Activation; Endothelial Cells; Hexanes; Humans; Inflammation; Leukocyte Rolling; Lipopolysaccharides; Lysophosphatidylcholines; Male; Membrane Lipids; Muscle, Skeletal; Myocardial Infarction; Myositis; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylcholine; Protein Structure, Quaternary; Random Allocation; Rats; Rats, Wistar; Receptors, IgG; Reperfusion Injury | 2014 |